World's First Oral Tirzepatide
World-Leading Peptide Drug Delivery Platforms
20%
mean weight loss in 36 weeks
60%
lower medication cost
50%
shorter treatmentduration
80%
higher market penetration
Technological Breakthroughs Triple Delivery Revolution
● Oral Formulations:First-in-class oral GLP-1R dual/tri- ple-targeting therapies,revolutionizing peptide bioavail-ability
● Microneedle Patches:Pain-free transdermal delivery enabling simultaneous GLP-1R/GIPR/GCGR activation
● Smart Gummies: pH-responsive sustained-release technology with glucose-dependent release mechanisms
1.47X
weight loss efficacy vs semaglutide
30%-50%
fewer side effects
92%
adherencerate
(6-month study)
5%
bioavailability
World-class manufacturing facilities and equipment
Technical Barriers
● Micro-Nano Host Polypeptide Carrier Technology: 300%enhanced epithelial absorption
●7-Day Sustained-Release Microsphere Technology:42% reduction in glycemic variability vs.semaglutide(p<0.01)
End-to-End Industrial IntegrationCore Technologies &FDA-Compliant Ingredients
●Independently synthesized Proprietary GLP-1R intermediates(>99.9%purity)
● FDA-compliant API manufacturing(DMF filed)
●Annual tirzepatide capacity:1,200 kg
Global Delivery Network
●China:API/intermediate production hubs
●Japan:Intermediate production facility
● Laos:Oral/microneedle formulation production site
●Hong Kong:Strategic logistics gateway
Special Offers
